Metaproterenol hemisulfate

Metaproterenol Sulfate (CAS No.: 5874-97-5) is a synthetic small molecule sympathomimetic and a beta adrenergic receptor agonist that is primarily categorized as a pharmacological tool compound for respiratory and inflammation related signaling research in biomedical discovery programs, with established activity at beta2 adrenergic receptors and reported inhibitory potency in the nanomolar range, making it suitable for mechanistic studies of receptor mediated cyclic AMP and protein kinase A associated signal transduction, downstream modulation of smooth muscle tone pathways, and context dependent regulation of inflammatory mediator production in cellular systems. In research settings, this compound is commonly applied to characterize beta2 receptor pharmacology, benchmark agonist responsiveness, and support target validation workflows in cell based assays, ex vivo tissue response models, and animal studies designed to investigate adrenergic control of airway associated biology and immune signaling interactions, while comparative profiling against related adrenergic ligands can further inform selectivity and pathway bias hypotheses relevant to hit to lead and translational pharmacology efforts. Reported in vitro effects are generally described from nanomolar to micromolar concentration ranges depending on assay format, receptor expression context, and endpoint selection, and the concentrations or doses used in experiments typically depend on specific experimental designs and research objectives.